GCL
LVAC

Glazer Capital LLC’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Glazer Capital LLC’s Portfolio LVAC Stock Details LVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-18,639
Closed -$194K – 348
2023
Q1 		$194K Sell
18,639
-5,021
-21% -$52K 0.01% 267
2022
Q4 		$242K Sell
23,660
-2,595
-10% -$26.3K 0.01% 359
2022
Q3 		$263K Sell
26,255
-155
-0.6% -$1.55K ﹤0.01% 450
2022
Q2 		$263K Sell
26,410
-150
-0.6% -$1.5K 0.01% 478
2022
Q1 		$264K Buy
+26,560
New +$264K 0.01% 402

Glazer Capital LLC's LVAC Position: Q2 2023 in Review

Glazer Capital LLC sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 18,639 shares — an estimated $194K sold.

Glazer Capital LLC first reported a position in LVAC in Q1 2022 and held it in 5 quarters. The position peaked at $264K in Q1 2022. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

  • Glazer Capital LLC reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Glazer Capital LLC sold 18,639 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $194K.
  • Glazer Capital LLC first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 5 quarters.
  • Glazer Capital LLC's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $264K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Glazer Capital LLC's 13F filing for Q2 2023, filed 14 Aug 2023.